We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+5.49%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$346M
AUM Growth
+$65.8M
Cap. Flow
-$8.87M
Cap. Flow %
-2.56%
Top 10 Hldgs %
48.65%
Holding
94
New
18
Increased
35
Reduced
23
Closed
15

Top Buys

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$9.02M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.78M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$4.51M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.21M
5
LOW icon
Lowe's Companies
LOW
+$3.74M

Top Sells

Rank Stock Value
1
JPM.WS
JPMorgan Chase
JPM.WS
+$17.5M
2
GILD icon
Gilead Sciences
GILD
+$8.83M
3
F icon
Ford
F
+$5.26M
4
BAC.WS.A
Bank Of America Corporation Ws A
BAC.WS.A
+$3.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.83M

Sector Composition

Rank Sector Weight
1 Healthcare 32.13%
2 Financials 12.03%
3 Communication Services 10.65%
4 Energy 9.04%
5 Technology 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLED icon
76
Universal Display
OLED
$3.75B
$219K 0.06%
+2,000
New +$211K
KITE
77
DELISTED
Kite Pharma, Inc.
KITE
$218K 0.06%
+2,100
New +$171K
NBTB icon
78
NBT Bancorp
NBTB
$2.82B
$201K 0.06%
+5,400
New +$200K
GCVRZ
79
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$5K ﹤0.01%
14,125
-1,525
-10% -$623
AMLP icon
80
Alerian MLP ETF
AMLP
$12.9B
– –
-4,573
Closed -$291K
EIDO icon
81
iShares MSCI Indonesia ETF
EIDO
$466M
– –
-67,595
Closed -$1.65M
EPU icon
82
iShares MSCI Peru and Global Exposure ETF
EPU
$521M
– –
-51,670
Closed -$1.6M
EWK icon
83
iShares MSCI Belgium ETF
EWK
$164M
– –
-130,613
Closed -$2.31M
F icon
84
Ford
F
$60.9B
– –
-413,351
Closed -$5.26M
GILD icon
85
Gilead Sciences
GILD
$165B
– –
-105,815
Closed -$8.83M
PACB icon
86
Pacific Biosciences
PACB
$435M
– –
-19,500
Closed -$137K
PEP icon
87
PepsiCo
PEP
$196B
– –
-2,083
Closed -$221K
PGEN icon
88
Precigen
PGEN
$1.94B
– –
-8,700
Closed -$214K
TUR icon
89
iShares MSCI Turkey ETF
TUR
$201M
– –
-47,700
Closed -$1.89M
UA icon
90
Under Armour Class C
UA
$2.95B
– –
-51,991
Closed -$1.89M
VIXY icon
91
ProShares VIX Short-Term Futures ETF
VIXY
$221M
– –
-19
Closed -$275K
SN
92
DELISTED
Sanchez Energy Corporation
SN
– –
-62,800
Closed -$443K
WFC.WS
93
DELISTED
Wells Fargo & Company Ws
WFC.WS
– –
-30,000
Closed -$409K
ETP
94
DELISTED
Energy Transfer Partners, L.P.
ETP
– –
-7,166
Closed -$220K
1 2 3
4

Similar funds

LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $781M AUM 27.1% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
RTM
RH Tailwind Management West Conshohocken, Pennsylvania $781M AUM
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
QCMNJ
Quantum Capital Management (New Jersey) Northfield, New Jersey $781M AUM 4.96% 1-Year Est. Return
TIS
Titan Investment Solutions London $781M AUM
MO
McMillan Office St. Clair Shores, Michigan $782M AUM

Biondo Investment Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Biondo Investment Advisors held 94 positions worth $346M, up 24% from $280M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Biondo Investment Advisors's Q2 2017 filing shows 18 new, 35 increased, 23 reduced and 15 closed positions. Its largest new stake was Abiomed Inc: 67,139 shares worth $9.62M. The largest sale was JPMorgan Chase, an estimated $17.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Financials and Communication Services.

  • Biondo Investment Advisors's largest Q2 2017 buy was Abiomed Inc: 67,139 shares worth $9.62M.
  • Biondo Investment Advisors added most to Regeneron Pharmaceuticals in Q2 2017, an estimated $5.78M increase.
  • Biondo Investment Advisors's biggest Q2 2017 reduction was JPMorgan Chase, cutting an estimated $17.5M.
  • Biondo Investment Advisors fully exited Gilead Sciences in Q2 2017, selling an estimated $8.83M.
  • Biondo Investment Advisors's ten largest holdings make up 49% of its $346M portfolio in Q2 2017.
  • Biondo Investment Advisors opened 18 new positions and closed 15 in Q2 2017.
  • Biondo Investment Advisors's portfolio value rose 24% quarter-over-quarter to $346M.

Based on Biondo Investment Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.